[1]
“Placebo- Controlled Trial of Pharmaceutical Optimized Captopril 60mg (F-9) in Patients with Essential Hypertension for Efficacy & Biochemical Evaluation”, mfm, vol. 27, no. 12, May 2024, Accessed: Dec. 27, 2025. [Online]. Available: https://medicalforummonthly.com/index.php/mfm/article/view/3630